Neurological complications of essential thrombocytosis (ET)

A. Kesler,M. Ellis,Y. Manor,N. Gadoth,M. Lishner

DOI: https://doi.org/10.1034/j.1600-0404.2000.102005299.x

2000-11-01

Acta Neurologica Scandinavica

Abstract:Objective– To evaluate the prevalence of neurological abnormalities in patients with ET and attempt to identify risk factors for neurological complications. Method– Ninety‐five patient charts were reviewed from January 1983–July 1999. Seventy patients fulfilled the Polycythemia Vera Study Group criteria for diagnosing ET. Results– Eighteen patients (25.7%) had episodes of neurological impairment, 52 (74.3%) had none. Neurological features – occlusive cerebrovascular event – 9; chronic headache – 3 and dizziness – 3, mononeuritis multiplex, sinus vein thrombosis and epilepsy – 1 each. The interval between diagnosis of ET and occurrence of neurological events ranged from time of presentation (10 patients) to 13 years (1 patient) with a high predominance of females, 88.8% and 55%, respectively. Conclusions– Neurological complications occurred at presentation or during follow‐up in approximately 25% of patients with ET. Our observation suggests that further investigation focusing on the possible mechanisms for neurological deficits in females with ET should be considered.